Featured Research

from universities, journals, and other organizations

HPV Vaccine Does Not Increase Risk Of Guillain-Barre Syndrome, Study Suggests

Date:
February 24, 2009
Source:
American Academy of Neurology
Summary:
The HPV vaccine does not increase the risk of developing Guillain-Barre syndrome, according to a new study. Guillain-Barre is a disorder that causes muscle weakness and tingling that can progress to paralysis.

 The HPV vaccine does not increase the risk of developing Guillain-Barré syndrome, according to a study released today that will be presented at the American Academy of Neurology's 61st Annual Meeting in Seattle, April 25 to May 2, 2009. Guillain-Barré is a disorder that causes muscle weakness and tingling that can progress to paralysis.

Although it can be life-threatening, most people recover with few remaining problems. The disorder often occurs after an infection; the body's immune system attacks the peripheral nervous system.

The vaccine was approved in June 2006 for use in girls and women age 9 to 26 to prevent infection with human papilloma virus (HPV) types that are the most common cause of cervical cancer. More than 16 million doses of the vaccine have been distributed.

For the study, researchers examined data from the Vaccine Adverse Event Reporting System, which is managed by the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA).

There were 36 cases of Guillain-Barré reported after HPV vaccination in the United States from 2006 to 2008. The disorder occurred within six weeks after vaccination in 75 percent of the people. In 20 of the people, or 60 percent, HPV was the only vaccine they received at the time, while 16 people, or 40 percent, received the HPV vaccine along with other vaccines.

"Our results show that Guillain-Barré is not occurring more often after HPV vaccination than it does in the general population," said study author Nizar Souayah, MD, of the University of Medicine and Dentistry of New Jersey in Newark and a member of the American Academy of Neurology. "However, the fact that most of these cases occurred within six weeks of vaccination does warrant careful monitoring for any additional cases and continued analysis."


Story Source:

The above story is based on materials provided by American Academy of Neurology. Note: Materials may be edited for content and length.


Cite This Page:

American Academy of Neurology. "HPV Vaccine Does Not Increase Risk Of Guillain-Barre Syndrome, Study Suggests." ScienceDaily. ScienceDaily, 24 February 2009. <www.sciencedaily.com/releases/2009/02/090213172045.htm>.
American Academy of Neurology. (2009, February 24). HPV Vaccine Does Not Increase Risk Of Guillain-Barre Syndrome, Study Suggests. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2009/02/090213172045.htm
American Academy of Neurology. "HPV Vaccine Does Not Increase Risk Of Guillain-Barre Syndrome, Study Suggests." ScienceDaily. www.sciencedaily.com/releases/2009/02/090213172045.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) — The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) — Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) — A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) — The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins